Anurag Mairal, PhD (He/His)

An inorganic membrane suitable for ultrafiltration or nanofiltration, and methods for making and using the membrane. The membrane has a organic polymer deposited on the feed surface, but is not able to perform separations by solution-diffusion.

A process for producing and recovering light alcohols, particularly ethanol, alcohol mixtures containing ethanol, and ABE mixtures (alcohol mixtures containing acetone, butanol and ethanol), using a combination of steps including fermentation, first membrane separation, dephlegmation and dehydration by second membrane separation.

A process and corresponding apparatus for dehydrating gas, especially natural gas. The process includes an absorption step and a membrane pervaporation step to regenerate the liquid sorbent.

A process and apparatus for treating oily wastewater, such as bilge water or ballast water, generated on a ship. The process uses a combination of a centrifugal separation step and a membrane separation step, such as an ultrafiltration step. The membrane separation step uses a dense, non-porous filtration membrane. The process is able to remove both emulsified oil and dissolved oil from the wastewater to low levels.

A membrane process for treating zein solutions to increase the zein concentration in the solution. The process uses a non-porous membrane that preferentially permeates the solvent and rejects the zein. Optionally, the process can be operated as a diafiltration process to yield a concentrate of high zein purity

Medical devices, and in particular implantable medical devices, may be coated to minimize or substantially eliminate a biological organism's reaction to the introduction of the medical device to the organism. The medical devices may be coated with any number of biocompatible materials. Therapeutic drugs, agents or compounds may be mixed with the biocompatible materials and affixed to at least a portion of the medical device. These therapeutic drugs, agents or compounds may also further reduce a… Show more

Medical devices, and in particular implantable medical devices, may be coated to minimize or substantially eliminate a biological organism's reaction to the introduction of the medical device to the organism. The medical devices may be coated with any number of biocompatible materials. Therapeutic drugs, agents or compounds may be mixed with the biocompatible materials and affixed to at least a portion of the medical device. These therapeutic drugs, agents or compounds may also further reduce a biological organism's reaction to the introduction of the medical device to the organism. In addition, these therapeutic drugs, agents and/or compounds may be utilized to promote healing, including the formation of blood clots. The drugs, agents, and/or compounds may also be utilized to treat specific diseases, including vulnerable plaque. Therapeutic agents may also be delivered to the region of a disease site. In regional delivery, liquid formulations may be desirable to increase the efficacy and deliverability of the particular drug. Also, the devices may be modified to promote endothelialization. Various materials and coating methodologies may be utilized to maintain the drugs, agents or compounds on the medical device until delivered and positioned. In addition, the devices utilized to deliver the implantable medical devices may be modified to reduce the potential for damaging the implantable medical device during deployment. Medical devices include stents, grafts, anastomotic devices, perivascular wraps, sutures and staples. These devices may also comprise thin films that perform a number of functions. In addition, various polymer combinations may be utilized to control the elution rates of the therapeutic drugs, agents and/or compounds from the implantable medical devices. Show less

A process for treating liquids containing organic compounds and water. The process includes a pervaporation step in conjunction with a dephlegmation step to treat at least a portion of the permeate vapor from the pervaporation step. The process yields a membrane residue stream, a stream enriched in the more volatile component (usually the organic) as the overhead stream from the dephlegmator and a condensate stream enriched in the less volatile component (usually the water) as a bottoms stream… Show more

A process for treating liquids containing organic compounds and water. The process includes a pervaporation step in conjunction with a dephlegmation step to treat at least a portion of the permeate vapor from the pervaporation step. The process yields a membrane residue stream, a stream enriched in the more volatile component (usually the organic) as the overhead stream from the dephlegmator and a condensate stream enriched in the less volatile component (usually the water) as a bottoms stream from the dephlegmator. Any of these may be the principal product of the process. The membrane separation step may also be performed in the vapor phase, or by membrane distillation. Show less